Home > News > Study: Nanoparticles to Deliver Therapy for Heaves in Horses
April 29th, 2012
Study: Nanoparticles to Deliver Therapy for Heaves in Horses
Abstract:
In a recent clinical study researchers at the equine clinic of the Department of Veterinary Medicine at Ludwig Maximilians University, Munich, Germany, designed a nanoscale molecule (called a nanoparticle) to deliver CpG-ODN, an immunostimulating DNA that has been shown to suppress allergies in humans, to horses. "CpG-ODN works by producing an anti-allergic and anti-inflammatory cytokine (IL 10) that modulates the immune system to 'switch away' from the allergy and inflammatory reaction," said researcher Heidrun Gehlen, PhD, DrMedVet, Dipl. ECEIM.
Source:
thehorse.com
| Related News Press |
News and information
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Discoveries
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||